Basilea Pharmaceutica AG
Patents, Design & Utilities

Last updated:

List of all Basilea Pharmaceutica AG patents 3 in total

Status Patent
Grant
Utility: Use of phospho-Akt as a biomarker of drug response External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles External link
Filling date: 7 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Process for the manufacture of isavuconazole or ravuconazole External link
Filling date: 7 Sep 2025 Issue date: 17 Mar 2020

Showing 1 to 3 of 3 patents.